He had his say. Now Glenn Krevlin’s waiting for the company to be put in play.
That would be NMT Medical Inc., where Krevlin has been quietly building a significant stake. During the second quarter ended June 30, the managing partner of New York hedge fund Glenhill Capital Advisors spent about $885,000 to purchase 525,000 shares. He now owns almost 1.8 million shares, or nearly 14 percent of NMT, and is far and away the company’s largest individual shareholder.